BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8554885)

  • 1. [Is "pulse dose rate" curietherapy comparable to low dose rate brachytherapy?].
    Lartigau E
    Bull Cancer Radiother; 1995; 82(3):336-9. PubMed ID: 8554885
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulse dose rate curietherapy].
    Mazeron JJ; Boisserie G; Baillet F
    Bull Cancer Radiother; 1995; 82(3):332-5. PubMed ID: 8554884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Time factor and curietherapy: the example of epidermoid carcinoma of the mobile tongue].
    Mazeron JJ; Mornex F
    Bull Cancer Radiother; 1990; 77(1):15-22. PubMed ID: 8703538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial gamma therapy using automated remote-control positioning of radiation sources in the treatment of malignant vaginal and vulvar neoplasms].
    Nechushkin MI; Mar'ina LA; Uĭmanov VA; Riabtseva AM
    Vopr Onkol; 1998; 44(5):599-603. PubMed ID: 9884724
    [No Abstract]   [Full Text] [Related]  

  • 5. Electronic brachytherapy: comparisons with external-beam and high-dose-rate 192Ir brachytherapy.
    Holt RW; Rivard MJ
    J Am Coll Radiol; 2008 Mar; 5(3):221-3. PubMed ID: 18312972
    [No Abstract]   [Full Text] [Related]  

  • 6. [First experience with a line source in gynecologic after-loading therapy].
    Bauer N; Tode D; Kaufhold S; Tode G
    Radiobiol Radiother (Berl); 1988; 29(1):51-8. PubMed ID: 3387535
    [No Abstract]   [Full Text] [Related]  

  • 7. Dosimetry of high dose rate intracavitary radiation therapy using Co-60 and Ir-192 sources.
    Lin FJ; Tu CP; Chen SS; Cheng TC; Lo YC
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):381-6. PubMed ID: 2794939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose rate in brachytherapy using after-loading machine: pulsed or high-dose rate?
    Hannoun-Lévi JM; Peiffert D
    Cancer Radiother; 2014 Oct; 18(5-6):437-40. PubMed ID: 25195117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy.
    Richter J; Baier K; Flentje M
    Strahlenther Onkol; 2008 Apr; 184(4):187-92. PubMed ID: 18398582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterpoint: the dose rate argument--Does size matter after all?
    Stewart AJ; Devlin PM; Mutyala S
    Brachytherapy; 2009; 8(3):273-5. PubMed ID: 19643374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interstitial radiotherapy using iridium-192].
    Veen RE
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2063-8. PubMed ID: 3683635
    [No Abstract]   [Full Text] [Related]  

  • 13. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the cervix: radiotherapy. Radiation substances and after-loading: low and high dose-rates.
    Snelling M
    Proc R Soc Med; 1973 Sep; 66(9):935-6. PubMed ID: 4805101
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
    Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer.
    Dickler A; Kirk MC; Coon A; Bernard D; Zusag T; Rotmensch J; Wazer DE
    Brachytherapy; 2008; 7(4):351-4. PubMed ID: 18783991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.